Healthcare provider profile · identity verified

Oleg Kaim, M.D.

Internal Medicine · ENGLEWOOD, NJ · NPI 1730133141

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	463	116
Amlodipine Besylate	Amlodipine Besylate	368	86
Levothyroxine Sodium	Levothyroxine Sodium	356	70
Losartan Potassium	Losartan Potassium	294	72
Metformin Hcl	Metformin Hcl	292	69
Rosuvastatin Calcium	Rosuvastatin Calcium	285	78
Metoprolol Succinate	Metoprolol Succinate	202	46
Escitalopram Oxalate	Escitalopram Oxalate	164	35
Hydrochlorothiazide	Hydrochlorothiazide	154	43
Pantoprazole Sodium	Pantoprazole Sodium	153	40
Simvastatin	Simvastatin	129	29
Omeprazole	Omeprazole	119	32
Lisinopril	Lisinopril	108	29
Zolpidem Tartrate	Zolpidem Tartrate	107	32
Tamsulosin Hcl	Tamsulosin Hcl	102	23
Olmesartan Medoxomil	Olmesartan Medoxomil	101	29
Atenolol	Atenolol	100	19
Clonidine Hcl	Clonidine Hcl	92	25
Eliquis	Apixaban	91	15
Alendronate Sodium	Alendronate Sodium	90	19
Gabapentin	Gabapentin	86	24
Azithromycin	Azithromycin	85	72
Alprazolam	Alprazolam	80	17
Clonazepam	Clonazepam	74	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	14
Chlorthalidone	Chlorthalidone	64	13
Metoprolol Tartrate	Metoprolol Tartrate	61	14
Januvia	Sitagliptin Phosphate	59	suppressed
Valsartan	Valsartan	54	14
Clopidogrel	Clopidogrel Bisulfate	51	11
Fluticasone Propionate	Fluticasone Propionate	47	16
Mirtazapine	Mirtazapine	47	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	45	14
Linzess	Linaclotide	45	suppressed
Irbesartan	Irbesartan	44	suppressed
Allopurinol	Allopurinol	42	suppressed
Vascepa	Icosapent Ethyl	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	28
Metformin Hcl Er	Metformin Hcl	40	suppressed
Furosemide	Furosemide	38	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Carvedilol	Carvedilol	37	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Ketoconazole	Ketoconazole	35	suppressed
Valacyclovir	Valacyclovir Hcl	34	13
Famotidine	Famotidine	33	13
Jardiance	Empagliflozin	32	suppressed
Lansoprazole	Lansoprazole	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Nystatin	Nystatin	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	13
Prednisone	Prednisone	31	19
Telmisartan	Telmisartan	31	suppressed
Lorazepam	Lorazepam	30	suppressed
Olanzapine	Olanzapine	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	25
Finasteride	Finasteride	29	suppressed
Glipizide Er	Glipizide	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Dutasteride	Dutasteride	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	12
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Febuxostat	Febuxostat	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Ramipril	Ramipril	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Colchicine	Colchicine	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Torsemide	Torsemide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error